Mesoblast Ltd risk profile
41 Elevated one input has moved against it
Measured 1 September 2026 from MESO's filed statements. Recomputed nightly.
41 (Elevated), driven by Leverage and coverage at 86, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 55 | Elevated | Volatile | One-year price volatility — 58.8% |
| Operating pressure | 0 | Contained | Stable | Costs outgrowing revenue — -483.9 percentage points |
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 86 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 45 | Elevated | Stable | Operating-margin gap against peers — -45.6 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.